Standout Papers

Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Mono... 2013 2026 2017 2021 491
  1. Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma (2013)
    William W. Busse, Stephen T. Holgate et al. American Journal of Respiratory and Critical Care Medicine
  2. A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease (2016)
    Stephan R. Targan, Brian G. Feagan et al. The American Journal of Gastroenterology

Immediate Impact

6 by Nobel laureates 26 from Science/Nature 83 standout
Sub-graph 1 of 16

Citing Papers

A natural experiment on the effect of herpes zoster vaccination on dementia
2025 StandoutNature
GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
10 intermediate papers

Works of Shao‐Lee Lin being referenced

Population PK and IgE Pharmacodynamic Analysis of a Fully Human Monoclonal Antibody Against IL4 Receptor
2011
A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma
2010
and 1 more

Author Peers

Author Last Decade Papers Cites
Shao‐Lee Lin 1054 628 998 21 2.3k
Yun Chon 1038 512 932 42 2.8k
W F Owen 1238 396 1021 22 2.6k
John J. Condemi 1264 1061 517 68 2.7k
Cornelis H. Wortel 339 397 848 14 2.5k
LA Aarden 430 347 1657 36 3.8k
Robert K. Zeldin 835 338 532 58 2.3k
Alain Sauty 514 570 1137 46 2.9k
Aaron A. Berlin 1055 984 1906 46 3.6k
James B. Whitmore 609 711 1503 63 3.9k
Phillip E. Korenblat 1971 1292 943 41 2.7k

All Works

Loading papers...

Rankless by CCL
2026